495 related articles for article (PubMed ID: 15345752)
1. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
2. (N)-methanocarba-2MeSADP (MRS2365) is a subtype-specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets.
Bourdon DM; Mahanty SK; Jacobson KA; Boyer JL; Harden TK
J Thromb Haemost; 2006 Apr; 4(4):861-8. PubMed ID: 16634757
[TBL] [Abstract][Full Text] [Related]
3. Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors.
Mamedova LK; Gao ZG; Jacobson KA
Biochem Pharmacol; 2006 Oct; 72(8):1031-41. PubMed ID: 16934758
[TBL] [Abstract][Full Text] [Related]
4. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a PI3-kinase independent pathway in the regulation of Rap1b activation downstream of the P2Y12 receptor in platelets.
Dangelmaier C; Kunapuli SP
Platelets; 2022 Nov; 33(8):1301-1306. PubMed ID: 35514261
[TBL] [Abstract][Full Text] [Related]
6. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
7. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide P2Y13-stimulated phosphorylation of CREB is required for ADP-induced proliferation of late developing retinal glial progenitors in culture.
Jacques FJ; Silva TM; da Silva FE; Ornelas IM; Ventura ALM
Cell Signal; 2017 Jul; 35():95-106. PubMed ID: 28347874
[TBL] [Abstract][Full Text] [Related]
9. Agonists and antagonists for P2 receptors.
Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
[TBL] [Abstract][Full Text] [Related]
10. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.
Costanzi S; Mamedova L; Gao ZG; Jacobson KA
J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of activation and functional role of protein kinase Ceta in human platelets.
Bynagari YS; Nagy B; Tuluc F; Bhavaraju K; Kim S; Vijayan KV; Kunapuli SP
J Biol Chem; 2009 May; 284(20):13413-13421. PubMed ID: 19286657
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.
Takasaki J; Kamohara M; Saito T; Matsumoto M; Matsumoto S; Ohishi T; Soga T; Matsushime H; Furuichi K
Mol Pharmacol; 2001 Sep; 60(3):432-9. PubMed ID: 11502873
[TBL] [Abstract][Full Text] [Related]
13. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
[TBL] [Abstract][Full Text] [Related]
14. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
17. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
18. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.
Schachter JB; Sromek SM; Nicholas RA; Harden TK
Neuropharmacology; 1997 Sep; 36(9):1181-7. PubMed ID: 9364473
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
20. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA
J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
